Mb, Levis & Associates, LLC Amicus Therapeutics, Inc. Transaction History
Mb, Levis & Associates, LLC
- $215 Billion
- Q1 2025
A detailed history of Mb, Levis & Associates, LLC transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Mb, Levis & Associates, LLC holds 500 shares of FOLD stock, worth $3,265. This represents 0.0% of its overall portfolio holdings.
Number of Shares
500
Previous 500
-0.0%
Holding current value
$3,265
Previous $4.71 Million
13.48%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding FOLD
# of Institutions
302Shares Held
279MCall Options Held
467KPut Options Held
515K-
Vanguard Group Inc Valley Forge, PA29.3MShares$191 Million0.0% of portfolio
-
Black Rock Inc. New York, NY24.4MShares$159 Million0.01% of portfolio
-
Perceptive Advisors LLC New York, NY24.2MShares$158 Million7.62% of portfolio
-
Avoro Capital Advisors LLC New York, NY23.2MShares$151 Million3.18% of portfolio
-
William Blair Investment Management, LLC Chicago, IL15.6MShares$102 Million0.38% of portfolio
About AMICUS THERAPEUTICS, INC.
- Ticker FOLD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 280,497,984
- Market Cap $1.83B
- Description
- Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...